01/18/2012 - 3:38pm

The Food and Drug Administration has provided guidance to Provectus Pharmaceuticals as the drug maker prepares to apply with the agency for approval to start a late-stage clinical trial of a drug for skin cancer, Provectus said Wednesday.

01/18/2012 - 12:26pm

Drug maker Gilead Sciences has completed its $11.2 billion acquisition of Pharmasset, Gilead said.

01/18/2012 - 11:08am

Laurry Hinds has been named regional director at BioPlus Specialty Pharmacy, responsible for business development in western North Carolina, the company announced.

01/13/2012 - 12:13pm

Bristol-Myers Squibb has officially launched its tender offer for Inhibitex, the drug maker said Friday.

01/12/2012 - 12:27pm

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

01/11/2012 - 2:47pm

Fleming Pharmaceuticals has sold rights of several of its products to Valeant International, Fleming said Wednesday.

01/10/2012 - 10:56am

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

01/09/2012 - 4:21pm

Diplomat Specialty Pharmacy has received limited distribution rights for a neovascular age-related macular degeneration treatment.

01/09/2012 - 1:21pm

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.